胰腺脂肪肉瘤1例报告

李书轩; 吴昊; 寇凯; 吕国悦

doi:10.3969/j.issn.1001-5256.2019.05.036

胰腺脂肪肉瘤1例报告

DOI: 10.3969/j.issn.1001-5256.2019.05.036

吉林大学第一医院肝胆胰外科

详细信息

中图分类号: R735.9
计量
- 文章访问数: 1122
- HTML全文浏览量: 18
- PDF下载量: 286
- 被引次数: 0
出版历程
- 出版日期: 2019-05-20

Pancreatic liposarcoma: A case report

Department of Hepatopancreatobiliary Surgery, The First Hospital of Jilin University

摘要

摘要: <正>1病例资料患者女性,72岁,因"胰腺占位1个月"于2018年1月10日就诊于本院。患者1个月前于当地医院体检行腹部CT检查提示:胰腺占位性病变。患者为求进一步诊治就诊于本院,既往史:高血压病史15年,血压最高200/100 mm Hg,未规律服用
- 胰腺肿瘤 /
- 脂肪肉瘤 /
- 诊断 /
- 治疗学 /
- 病例报告
- pancreatic neoplasms /
- liposarcoma /
- diagnosis /
- therapeutics /
- case reports

HTML全文

参考文献(25)

[1] KOPLIN SA, TWOHIG MH, LUND DP, et al. Omental lipoblastoma[J]. Pathol Res Pract, 2008, 204 (4) :277-281.

[2] CRAGO AM, SINGER S. Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma[J]. Curr Opin Oncol, 2011, 23 (4) :373-378.

[3] DODO IM, ADAMTHWAITE JA, JAIN P, et al. Successful outcome following resection of a pancreatic liposarcoma with solitary metastasis[J]. World J Gastroenterol, 2005, 11 (48) :7684-7685.

[4] TSILI AC, TSAMPOULAS C, GIANNAKOPOULOS X, et al. MRI in the histologic characterization of testicular neoplasms[J]. AJR Am J Roentgenol, 2007, 189 (6) :331-337.

[5] PETERSON JJ, KRANSDORF MJ, BANCROFT LW, et al. Malignant fatty tumors:Classification, clinical course, imaging appearance and treatment[J]. Skeletal Radiol, 2003, 32:493-503.

[6] SHEAH K, OUELLETTE H A, TORRIANI M, et al. Metastatic myxoid liposarcomas:Imaging and histopathologic findings[J]. Skeletal Radiol, 2008, 37 (3) :251-258.

[7] SEO SW, KWON J W, JANG S W, et al. Feasibility of wholebody MRI for detecting metastatic myxoid liposarcoma:A case series[J]. Orthopedics, 2011, 34 (11) :748-754.

[8] ELLIOTT TE, ALBERTAZZI VJ, DANTO LA. Pancreatic liposarcoma:Case report with review of retroperitoneal liposarcomas[J]. Cancer, 1980, 45 (7) :1720-1723.

[9] IKEGUCHI M, URUSHIBARA S, SHIMODA R, et al. Surgical treatment of retroperitoneal liposarcoma[J]. Yonago Acta Med, 2014, 57 (4) :129-132.

[10] SINGER S, ANTONESCU CR, RIEDEL E, et al. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma[J]. Ann Surg, 2003, 238 (3) :358-370.

[11] DESAI J. The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma[J]. Am Soc Clin Oncol Educ Book, 2013, 2013 (2013) :386-393.

[12] HAN T, LUAN Y, XU Y, et al. Successful treatment of advanced pancreatic liposarcoma with apatinib:A case report and literature review[J]. Cancer Biol Ther, 2017, 18 (9) :635-639.

[13] SCHWAB JH, BOLAND P, GUO T, et al. Skeletal metastases in myxoid liposarcoma:An unusual pattern of distant spread[J]. Ann Surg Oncol, 2007, 14 (4) :1507-1514.

[14] HANIBALL J, SUMATHI VP, KINDBLOM LG, et al. Prognostic factors and metastatic patterns in primary myxoid/round-cell liposarcoma[J]. Sarcoma, 2011, 2011 (1) :1-10.

[15] ZERBI A, PECORELLI N. Pancreatic metastases:An increasing clinical entity[J]. World J Gastrointest Surg, 2010, 2 (8) :255-259.

[16] BEHRANWALA KA, ROY P, GIBLIN V, et al. Intra-abdominal metastases from soft tissue sarcoma[J]. J Surg Oncol, 2010, 87 (3) :116-120.

[17] ADSAY NV, ANDEA A, BASTURK O, et al. Secondary tumors of the pancreas:An analysis of a surgical and autopsy database and review of the literature[J]. Virchows Arch, 2004, 444 (6) :527-535.

[18] MINNI F, CASADEI R, PERENZE B, et al. Pancreatic metastases:Observations of three cases and review of the literature[J]. Pancreatology, 2004, 4 (6) :509-520.

[19] MCKEE MD, LIU DF, BROOKS JJ, et al. The prognostic significance of margin width for extremity and trunk sarcoma[J].J Surg Oncol, 2004, 85 (2) :68-76.

[20] LIU CY, YEN CC, CHEN WM, et al. Soft tissue sarcoma of extremities:The prognostic significance of adequate surgical margins in primary operation and reoperation after recurrence[J]. Ann Surg Oncol, 2010, 17 (8) :2102-2111.

[21] SPERTI C, PASQUALI C, LIESSI G, et al. Pancreatic resection for metastatic tumors to the pancreas[J]. J Surg Oncol, 2003, 83 (3) :161-166.

[22] ROBERT PE, ORRY D, MOR C, et al. Resectable pancreatic metastasis of left thighbone leiomyosarcoma:Case report and literature review[J]. J Gastrointest Cancer, 2012, 43 (1) :40-43.

[23] GUADAGNOLO BA, ZAGARS GK, BALLO MT, et al. Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy[J].Int J Radiat Oncol Biol Phys, 2008, 70 (3) :760-765.

[24] ITALIANO A, TOULMONDE M, CIOFFI A, et al. Advanced well-differentiated/dedifferentiated liposarcomas:Role of chemotherapy and survival[J]. Ann Oncol, 2012, 23 (6) :1601-1607.

[25] GRONCHI A, BUI BN, BONVALOT S, et al. Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma[J]. Ann Oncol, 2012, 23 (3) :771-776.

施引文献

资源附件(0)

访问统计